Flow cytometry analysis showed no significant differences in CD69+CD25−, CD69+CD25+, and CD69−CD25+ subpopulations with or without activation, between PD and healthy controls, although there was a significant increase in percent of each subpopulation upon activation within each group (Supplementary Fig. 5). This evidence concerns the gene CD69 and Parkinson disease.